CVS Health Corp (CVS)
NYSE:CVS
Want to see CVS full AI Analyst Report?
CVS Stock Chart & Stats
$77.30
-$0.04(-0.09%)
At close: 4:00 PM EST
$77.30
-$0.04(-0.09%)
Day’s Range― - ―
52-Week Range$58.50 - $98.43
Previous CloseN/A
Volume5.40M
Average Volume (3M)8.51M
Market Cap
$118.99B
Enterprise Value$187.80B
Total Cash (Recent Filing)$11.80B
Total Debt (Recent Filing)$78.34B
Price to Earnings (P/E)7.8
Beta0.58
Next Earnings
Aug 05, 2026EPS Estimate
1.83Next Dividend Ex-DateN/A
Dividend Yield3.41%
Share Statistics
EPS (TTM)2.31
Shares Outstanding1,275,927,200
10 Day Avg. Volume9,482,466
30 Day Avg. Volume8,511,433
Financial Highlights & Ratios
PEG Ratio-0.92
Price to Book (P/B)1.34
Price to Sales (P/S)0.25
P/FCF Ratio12.88
Enterprise Value/Market Cap1.58
Enterprise Value/Revenue0.46
Enterprise Value/Gross Profit3.32
Enterprise Value/Ebitda16.87
Forecast
1Y Price Target
$102.89Price Target Upside33.10% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering18
EPS Forecast (FY)7.38
Revenue Forecast (FY)$407.26B
Bulls Say, Bears Say
Bulls Say
Guidance ClarityInvestor-day guidance and a reaffirmation of revenue and operating income targets reduce uncertainty around quarterly results, lowering the risk of earnings surprises for the stock.
Medicare Advantage MarginsAnalyst expects disciplined Medicare Advantage pricing and benefit changes to improve insurer unit margins, supporting a path to stronger earnings and potential valuation re-rating.
Retail Pharmacy PerformanceRetail pharmacy market share gains and large prescription purchases have supported steadier pharmacy revenue, which could boost retail operating income and investor confidence in the segment.
Bears Say
Cash Flow And Working CapitalLowered cash flow expectations driven by payment timing and working capital shifts could limit near-term cash availability and constrain capital deployment decisions.
Medical Cost PressureElevated medical costs across product lines continue to pressure profitability for the insurer, threatening the pace of margin recovery despite operational improvements.
PBM Business Model RiskAnalyst warns that ongoing pressure on pharmacy benefit manager margins and a market shift toward fee-based compensation could materially reduce PBM profitability and weigh on overall earnings growth.
CVS Health News
CVS FAQ
What was CVS Health Corp’s price range in the past 12 months?
CVS Health Corp lowest stock price was $58.50 and its highest was $98.43 in the past 12 months.
What is CVS Health Corp’s market cap?
CVS Health Corp’s market cap is $118.99B.
When is CVS Health Corp’s upcoming earnings report date?
CVS Health Corp’s upcoming earnings report date is Aug 05, 2026 which is in 72 days.
How were CVS Health Corp’s earnings last quarter?
CVS Health Corp released its earnings results on May 06, 2026. The company reported $2.57 earnings per share for the quarter, beating the consensus estimate of $2.184 by $0.386.
Is CVS Health Corp overvalued?
According to Wall Street analysts CVS Health Corp’s price is currently Undervalued.
Does CVS Health Corp pay dividends?
CVS Health Corp pays a Quarterly dividend of $0.665 which represents an annual dividend yield of 3.41%. See more information on CVS Health Corp dividends here
What is CVS Health Corp’s EPS estimate?
CVS Health Corp’s EPS estimate is 1.83.
How many shares outstanding does CVS Health Corp have?
CVS Health Corp has 1,275,927,200 shares outstanding.
What happened to CVS Health Corp’s price movement after its last earnings report?
CVS Health Corp reported an EPS of $2.57 in its last earnings report, beating expectations of $2.184. Following the earnings report the stock price went up 7.647%.
Which hedge fund is a major shareholder of CVS Health Corp?
Currently, no hedge funds are holding shares in CVS
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
CVS Health Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$102.89 (33.10% Upside)
$102.89 (33.10% Upside)
Blogger Sentiment
Bullish
CVS Sentiment 70%
Sector Average ―
Sector Average ―
Hedge Fund Trend
Decreased
By 9.8M Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $323.7M over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Negative
Last 7 Days ▼ 0.6%
Last 30 Days ▼ 1.1%
Last 30 Days ▼ 1.1%
News Sentiment
Bullish
Bullish news 79%
Bearish news 29%
Bearish news 29%
Technicals
SMA
Positive
20 days / 200 days
Momentum
60.53%
12-Months-Change
Fundamentals
Return on Equity
3.87%
Trailing 12-Months
Asset Growth
-1.02%
Trailing 12-Months
Company Description
CVS Health Corp
CVS Health Corporation provides health services in the United States. The company's Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services. It serves employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers, governmental units, government-sponsored plans, labor groups, and expatriates. Its Pharmacy Services segment offers pharmacy benefit management solutions, including plan design and administration, formulary management, retail pharmacy network management, mail order pharmacy, specialty pharmacy and infusion, clinical, and disease and medical spend management services. It serves employers, insurance companies, unions, government employee groups, health plans, prescription drug plans, Medicaid managed care plans, plans offered on public health insurance and private health insurance exchanges, other sponsors of health benefit plans, and individuals. This segment operates retail specialty pharmacy stores; and specialty mail-order, mail-order dispensing, and compounding pharmacies, as well as branches for infusion and enteral nutrition services. The company's Retail/LTC segment sells prescription and over-the-counter drugs, consumer health and beauty products, and personal care products; and provides health care services through its MinuteClinic walk-in medical clinics. This segment also distributes prescription drugs; and provides related pharmacy consulting and other ancillary services to care facilities and other care settings. As of December 31, 2021, it operated approximately 9,900 retail locations and 1,200 MinuteClinic locations, as well as online retail pharmacy websites, LTC pharmacies, and onsite pharmacies. The company was formerly known as CVS Caremark Corporation and changed its name to CVS Health Corporation in September 2014. CVS Health Corporation was founded in 1963 and is headquartered in Woonsocket, Rhode Island.
CVS Company Deck
CVS Earnings Call
Q1 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call conveyed a generally positive tone driven by clear top-line growth, strong cash generation, profit and EPS beats, an upward revision to full-year EPS guidance, meaningful improvement at Aetna (material AOI gain and operational efficiencies), and ongoing technology/AI initiatives (Health100). Offsetting risks include segment-level profit declines (Health Services and PCW), membership impacts from the Individual Exchange exit, continued elevated medical cost trends, PBM rebate pressures and regulatory/state-level uncertainty. On balance, the favorable operating metrics, raised guidance, and credible path to margin recovery outweighed the identifiable challenges.View all CVS earnings summariesCVS Revenue Breakdown
46.57% Health Services
35.05% Health Care Benefits
33.40% Pharmacy & Consumer Wellness
0.12% Corporate/ Other
CVS Stock 12 Month Forecast
Average Price Target
$102.89
▲(33.10% Upside)
Technical Analysis
Ownership Overview
0.42% Insiders
32.97% Mutual Funds
26.05% Other Institutional Investors
17.95% Public Companies and Individual Investors